Note 8 - Segment Information

6 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company

’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing,

Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

December

31,

2016

and

2015

were

$1,797

and

$1,826,

respectively and for the

six

months ended

December

31,

2016

and

2015

were

$4,673

and

$3,818,

respectively.

Financial information relating to the

three

months ended

December

31,

2016

and

2015

operations by business segment are as follows:

		Sales, Net			Segment
		U.S.	International		Gross		Capital
		Customers	Customers	Total	Profit (loss)	Depreciation	Expenditures
Contract Manufacturing	2016	$ 10,207	$ 1,687	$ 11,894	$ 1,344	$ 80	$ 42
	2015	8,077	1,814	9,891	842	55	176
Branded Proprietary Products	2016	61	101	162	17	-	-
	2015	84	3	87	(19)	-	-
Other Nutraceutical Businesses	2016	307	9	316	109	-	-
	2015	426	9	435	152	1	-
Total Company	2016	10,575	1,797	12,372	1,470	80	42
	2015	8,587	1,826	10,413	975	56	176

Financial

information relating to the

six

months ended

December

31,

2016

and

2015

operations by business segment are as follows:

		Sales, Net			Segment
		U.S.	International		Gross		Capital
		Customers	Customers	Total	Profit (loss)	Depreciation	Expenditures
Contract Manufacturing	2016	$ 19,528	$ 4,398	$ 23,926	$ 3,240	$ 151	$ 83
	2015	15,007	3,629	18,636	1,883	114	230
Branded Proprietary Products	2016	90	196	286	51	-	-
	2015	232	175	407	109	-	-
Other Nutraceutical Businesses	2016	762	79	841	330	1	1
	2015	802	14	816	298	1	1
Total Company	2016	20,380	4,673	25,053	3,621	152	84
	2015	16,041	3,818	19,859	2,290	115	231

	Total Assets as of
	December 31,	June 30,
	2016	2016
Contract Manufacturing	$ 12,674	$ 11,853
Branded Proprietary Products	746	676
Other Nutraceutical Businesses	1,578	1,556
Total Company	$ 14,998	$ 14,085